Zurück zur Gesamtübersicht

Springer Nature AG & Co. KGaA

ISIN: DE000SPG1003

WKN: SPG100

13 Mai 2025 07:00AM

EQS-News: Springer Nature reports strong start to 2025

Springer Nature AG & Co. KGaA · ISIN: DE000SPG1003 · EQS - Company News

Land: Deutschland · Primärmarkt: Deutschland · EQS News ID: 2135406

EQS-News: Springer Nature AG & Co. KGaA / Key word(s): Quarterly / Interim Statement/Quarterly / Interim Statement
Springer Nature reports strong start to 2025

13.05.2025 / 07:00 CET/CEST
The issuer is solely responsible for the content of this announcement.

PRESS RELEASE

Springer Nature reports strong start to 2025

Revenue grew by 6% and adjusted operating profit (AOP) increased by 11% in the first three months of 2025; both on an underlying[1] basis
Research was the key growth driver, led by strong performance in Full Open Access (FOA)
Strategic priorities on track: Solid progress in Open Access (OA) and AI initiatives
Full-year 2025 guidance now includes an AOP range; results expected in the upper half of the revenue and AOP ranges

Berlin, 13 May 2025

Springer Nature, a leading global publisher of research, today released strong results for the first three months of its financial year 2025. Revenue grew to €450 million, representing a 6% increase on an underlying¹ basis compared to the same period last year. Adjusted operating profit reached €108 million, equating to underlying¹ growth of 11%, which was mainly the result of positive revenue development during the quarter.

Frank Vrancken Peeters, CEO of Springer Nature, said: “These strong first-quarter results reflect the fact that we continue to successfully deliver on our strategy to grow sustainably and to add value to our communities. I am particularly pleased with the growth in the amount of content we are making immediately open for all to use, while continuing to invest in people and technology, and to safeguard research integrity.”

In the reported period, Research was a key contributor to Springer Nature's performance seeing an underlying¹ revenue growth of 7%. This was led by a strong performance in open access (OA) including an increase of about 25%[2] on prior year in published articles in its full open access (FOA) journals. Fourteen new transformative agreements were also agreed, taking the total to 80, further driving the global OA transition. In addition, around 90% of contract renewals for 2025 have already been completed.

Two new Nature review journals (Nature Reviews Clean Technology and Nature Reviews Biodiversity) were launched, supporting researchers in new emerging fields.

Springer Nature continued to invest in technology to transform the publishing process. Snapp, the company’s proprietary article processing platform, saw submission growth of 80% in the first quarter, which includes newly migrated journals. Springer Nature also launched new AI tools to help ensure research integrity.

Health generated revenue of €41 million, with 4% underlying [3] revenue growth in the first three months of 2025. Growth was driven by strong demand in the international pharma business and BSL in the Netherlands. Education revenue was broadly flat on an underlying³ basis at €54 million in the first three months, with negative revenue phasing in Southern Africa balancing strong performance in the Southern hemisphere.

Springer Nature retained its focus on growing responsibly – reducing its impact on the planet, maintaining strong customer satisfaction and investing in creating a great place to work. In January, the company was once again recognised as a leading employer in Germany, the UK and the US by the LEADING EMPLOYERS study.

Free cash flow increased to €158 million from €142.5 in the same period last year. This was mainly the results of operational improvement as well as lower interest payments. Consequently, Springer Nature further reduced its financial leverage ratio to 2.0x net debt/EBITDA from 2.3x at the end of 2024.

Alexandra Dambeck, the company’s CFO, said: “We have succeeded in further improving both our operating performance and financial leverage, continuing our strong trajectory from last year. Therefore, we are confident in refining our 2025 guidance and expect to be in the upper half of the ranges.”

Springer Nature's guidance is based on the underlying³ performance and constant foreign exchange rates. The company has refined its full-year 2025 guidance and now expects results to be in the upper half of the previously communicated revenue range of €1,885 million to €1,935 million. Springer Nature has also introduced an adjusted operating profit range of €523 million to €546 million, with expectations likewise toward the upper half of this range. The company’s mid-term outlook remains unchanged.

Springer Nature financial KPI Q1 2025

Key performance indicators

in € million	3M 2025	3M 2024	Change	Underlying change
Revenue	450.3	429.2	4.9%	5.6%
Adjusted operating profit	107.9	98.8	9.2%	10.5%
Adjusted operating profit margin	24.0%	23.0%	93bps	107bps
Free cash flow	158.0	142.5	15.5

Revenue

in € million	3M 2025	3M 2024	Change	Underlying change
Group	450.3	429.2	4.9%	5.6%
Segments Research^a,b	354.9	331.7	7.0%	6.7%
Health	41.1	39.2	4.9%	4.3%
Education^c	54.4	58.8	(7.4%)	(0.7%)
Consolidation	(0.3)	(0.6)

a      American Journal Experts (AJE), the language-editing business, sold in February 2024, contributed revenue of €3.1 million.
b      The Professional segment was integrated in the Research segment as at 1 January 2025. The presentation of the previous year has been adjusted accordingly.
c      Education reported revenue and AOP in Q1 2024 have been amended for a hyperinflation related accounting adjustment in Zimbabwe. The adjustment did not have an effect on H1 2024, or the FY 2024 reported figures of the segment or the Group.

Adjusted operating profit

in € million	3M 2025	3M 2024	Change	Underlying Change
Group	107.9	98.8	9.2%	10.5%
Segments Research^a	99.5	90.2	10.3%	7.7%
Health	4.5	3.7	22.8%	21.9%
Education^b	3.7	4.9	(23.5%)	>200.0%
Consolidation	0.1	0.0

a The Professional segment was integrated in the Research segment as at 1 January 2025. The presentation of the previous year has been adjusted accordingly.
b Education reported revenue and AOP in Q1 2024 have been amended for a hyperinflation related accounting adjustment in Zimbabwe. The adjustment did not have an effect on H1 2024, or the FY 2024 reported figures of the segment or the Group.

Notes relating to forward-looking statements
This document contains statements about the future business development and strategic direction of the company. The forward-looking statements are based on management's current expectations and assumptions. They are subject to certain risks and fluctuations as described in other publications, in particular in the risk and opportunities management section of the combined management report. If these expectations and assumptions do not apply or if unforeseen risks arise, the actual course of business may differ significantly from the expected developments. We therefore assume no liability for the accuracy of these forecasts.

About Springer Nature
Springer Nature is one of the leading publishers of research in the world. We publish the largest number of journals and books and are a pioneer in open research. Through our leading brands, trusted for more than 180 years, we provide technology-enabled products, platforms and services that help researchers to uncover new ideas and share their discoveries, health professionals to stay at the forefront of medical science, and educators to advance learning. We are proud to be part of progress, working together with the communities we serve to share knowledge and bring greater understanding to the world. For more information, please visit about.springernature.com and @SpringerNature.

Contact

Cornelius Rahn | Springer Nature | Communications and Corporate Affairs
tel +49 151 1563 7515 | cornelius.rahn@springernature.com

^[1] Underlying changes excludes effects from year-on-year changes in foreign currencies and portfolio.

^[2] Excluding Cureus.

^[3] Underlying changes excludes effects from year-on-year changes in foreign currencies and portfolio.

13.05.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language:	English
Company:	Springer Nature AG & Co. KGaA
	Heidelberger Platz 3
	14197 Berlin
	Germany
Phone:	+49 (0)30 - 82787 - 0
E-mail:	ir@springernature.com
Internet:	www.springernature.com
ISIN:	DE000SPG1003
WKN:	SPG100
Indices:	SDAX
Listed:	Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange (Vienna MTF)
EQS News ID:	2135406


End of News	EQS News Service

2135406 13.05.2025 CET/CEST

More Research

Unterstützung für Ihre Aktien-Analyse

Zur besseren Einschätzung der fundamentalen Entwicklung der jeweiligen Unternehmen bietet boersengefluester.de (BGFL) eine Übersicht mit den wesentlichen Kennzahlen zu Umsatz, Ergebnis, Cashflow und Dividende. Sämtliche Angaben werden manuell in unserer Datenbank erfasst – Quelle sind die jeweiligen Geschäftsberichte. Sofern es sich um Schätzungen für künftige Zahlen handelt, stammen sie durchweg von BGFL.

Die wichtigsten Finanzdaten auf einen Blick
	2019	2020	2021	2022	2023	2024	2025e
Umsatzerlöse¹	0,00	1.626,70	1.700,90	1.821,80	1.853,00	1.847,10	1.950,00
EBITDA^1,2	0,00	592,30	642,00	679,50	746,80	678,50	760,00
EBITDA-Marge³	0,00	36,41	37,75	37,30	40,30	36,73	38,97
EBIT^1,4	0,00	264,70	307,50	386,90	461,70	394,60	550,00
EBIT-Marge⁵	0,00	16,27	18,08	21,24	24,92	21,36	28,21
Jahresüberschuss¹	0,00	28,00	-9,00	199,50	15,70	69,00	91,00
Netto-Marge⁶	0,00	1,72	-0,53	10,95	0,85	3,74	4,67
Cashflow^1,7	0,00	570,20	610,80	504,80	491,90	531,20	540,00
Ergebnis je Aktie⁸	0,23	0,13	-0,05	1,00	0,08	0,34	0,45
Dividende⁸	0,00	0,00	0,00	0,00	0,00	0,13	0,15

Quelle: boersengefluester.de und Firmenangaben

Legende

¹ in Mio. Euro; ² EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; ³ EBITDA in Relation zum Umsatz; ⁴ EBIT = Ergebnis vor Zinsen und Steuern; ⁵ EBIT in Relation zum Umsatz; ⁶ Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; ⁷ Cashflow aus der gewöhnlichen Geschäftstätigkeit; ⁸ in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Ernst & Young

Die wichtigsten Kennzahlen auf einen Blick

Alle relevanten Bewertungskennzahlen, Termine und sonstige Investor-Informationen zu Ihrer Aktie kompakt zusammengefasst. Gut zu wissen: Sämtliche Daten stammen von boersengefluester.de werden täglich aktualisiert. Damit sind Sie immer auf dem neuen Stand. Kurze Erkärungen zu den Kennzahlen bekommen Sie, wenn Sie mit dem Cursor bzw. der Maus auf das jeweilige Feld gehen.

INVESTOR-INFORMATIONEN
©boersengefluester.de
Springer Nature
WKN	ISIN	Rechtsform	Börsenwert	IPO	Einschätzung	Plus Code
SPG100	DE000SPG1003	AG & Co. KGaA	3.617,99 Mio €	04.10.2024		9F4MF8H6+CP

* * *

KGV 2026e	KGV 10Y-Ø	BGFL-Ratio	Shiller-KGV	KBV	KCV	KUV
36,94	40,22	0,92	175,73	2,03	6,81	1,96

Dividenden

Dividende '2023 in €	Dividende '2024 in €	Dividende '2025e in €	Div.-Rendite '2025e in %
0,00	0,13	0,15	0,82%

Finanztermine

Hauptversammlung	Q1-Zahlen	Q2-Zahlen	Q3-Zahlen	Bilanz-PK
05.06.2025	13.05.2025	13.08.2025	12.11.2025	31.03.2025

Performance-Angaben

Abstand 60-Tage-Linie	Abstand 200-Tage-Linie	Performance YtD	Kursveränderung 52 Wochen	IPO	Akt. Kurs (EoD) +1,33% 18,34 € ATH 28,30 €
-16,26%	-12,18%	-32,57%	-29,46%	-18,49%	Akt. Kurs (EoD) +1,33% 18,34 € ATH 28,30 €

LEI: 549300UMNC43HQB3JA96

Social Media-Kanäle

Werbung ist für uns ein wichtiger Einnahmekanal. Aber wir verstehen, dass sie manchmal lästig wird. Wenn Sie die Anzahl der angezeigten Werbung reduzieren möchten, loggen Sie sich einfach in Ihr Benutzerkonto ein und verwalten Sie die Einstellungen von dort aus. Als registrierter Benutzer erhalten Sie viele Vorteile.

EQS-News: Springer Nature reports strong start to 2025

#BGFL

Netzwerk

Partner

Kontakt

EQS-News: Springer Nature reports strong start to 2025

Sie möchten weniger Werbung sehen? Registrieren Sie sich einfach für ein Benutzerkonto. Die Registrierung ist kostenlos und reduziert die Anzahl spürbar.

#BGFL

Netzwerk

Partner

Kontakt